• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROMODULATION INTERSTIM; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROMODULATION INTERSTIM; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE Back to Search Results
Model Number NEU_INTERSTIM_INS
Device Problems Unintended Collision (1429); Energy Output Problem (1431); Insufficient Information (3190)
Patient Problems Calcium Deposits/Calcification (1758); Nerve Damage (1979); Urinary Retention (2119); Urinary Tract Infection (2120); Therapeutic Response, Decreased (2271); Anxiety (2328); Distress (2329); Complaint, Ill-Defined (2331); Injury (2348); Malaise (2359)
Event Date 03/01/2015
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Information received from a consumer via the manufacturer representative (rep) reported an index accident occurred in (b)(6) 2015.The patient was wearing a seatbelt at the time of the accident.The index accident involved a low velocity impact to the passengers front side, at approximately 15 to 20 miles per hour (mph).It was accepted by insurers that the accident occasioned damage to the patient's left shoulder caused which required substantial surgery, rotator cuff repair.It was further accepted that the system connection had damaged the nerves to my bowel.They now have permanent damage to their lower bowel with no bowel problems prior to the accident.The insurers agreed their bowel was damaged by the accident, following a report by an independent neurologist.These matters were noted as a matter of background only.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from the consumer reporting that the device system worked excellently, brilliantly, and was a godsend until the accident.The accident was on the driver¿s front side.The sacral nerve stimulation (sns) was damaged from the accident.Further stated probability of damage, malfunction, disconnection, and displace/migrated caused by the accident.Significant effectiveness of the sns diminished following the accident.The patient has not been well and has suffered repeated infections, which they never had prior to the accident.The patient¿s bowel was injured.Two or three weeks after the accident the patient experienced dramatic deterioration in urological functioning/symptoms, and in physical and emotional confidence.The patient suffered dramatic loss of confidence and considerate mental distress and anxiety.There was fast escalating incidence and alarming frequency of urinary infection, further stated regular urinary infection on a month to six weekly basis.Six months of botox injections were performed after the accident, which vastly improved and established condition prior to the accident but was temporary.In (b)(6) 2015 the patient was potentially diagnosed with bladder stones, which they never suffered before.The patient has to revert to a leg bag.X-ray of the lead on (b)(6) 2018 was unable to determine whether the lead had or had not been displaced or migrated.The patient may need major urological surgery.Past medical history included: tendon injury triggering a neurological change resulting in bladder injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTERSTIM
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE
Manufacturer (Section D)
MEDTRONIC NEUROMODULATION
7000 central ave ne
minneapolis MN 55432
MDR Report Key10088231
MDR Text Key192038258
Report Number2182207-2020-00254
Device Sequence Number1
Product Code EZW
Combination Product (y/n)N
PMA/PMN Number
P970004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Type of Report Initial,Followup,Followup
Report Date 08/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberNEU_INTERSTIM_INS
Device Catalogue NumberNEU_INTERSTIM_INS
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/12/2020
Initial Date FDA Received05/26/2020
Supplement Dates Manufacturer Received07/27/2020
07/27/2020
Supplement Dates FDA Received08/24/2020
08/24/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Disability;
-
-